Haiyu Zhou
Guangzhou University of Chinese Medicine(CN)Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Fujian Medical University(CN)Guangxi University(CN)Binzhou University(CN)Hunan Normal University(CN)Huazhong Agricultural University(CN)Ministry of Natural Resources(CN)Biomedical Advanced Research and Development Authority(US)Shandong Tumor Hospital(CN)Moderna Therapeutics (United States)(US)China Academy of Safety Sciences and Technology(CN)Ministry of Agriculture(ID)Guangxi Academy of Agricultural Science(CN)Lanzhou University Second Hospital(CN)Changsha Hospital for Maternal and Child Health Care(CN)Guangdong Academy of Medical Sciences(CN)Guangdong Provincial People's Hospital(CN)State Key Laboratory of Chemical Engineering(CN)Qilu Hospital of Shandong University(CN)Shandong First Medical University(CN)YangPu Geriatric Hospital(CN)Yangpu Hospital of Tongji University(CN)Southern Medical University(CN)Lanzhou University(CN)Nanjing Medical University(CN)South China University of Technology(CN)Tsinghua University(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, Lung Cancer Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, Radiomics and Machine Learning in Medical Imaging, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Pembrolizumab versus Ipilimumab in Advanced Melanoma(2015)5,779 cited
- → Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)(2017)1,220 cited
- → Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial(2022)1,177 cited
- → Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase(2021)653 cited
- → A Bivalent Omicron-Containing Booster Vaccine against Covid-19(2022)641 cited
- → Translating the Diabetes Prevention Program into the Community(2008)640 cited